Biotechnology

UnitedHealth’s guidance cut may mean trouble for more insurers
UnitedHealth Group‘s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in ...

Exclusive: Biotech startup Profluent says it has found “scaling laws” for AI models for protein design
A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing ...

Pfizer scraps daily weight loss pill danuglipron after a liver injury
Kena Betancur | Corbis News | Getty Images Pfizer on Monday said it would end development of its experimental daily ...

Pharma tariff relief likely short-lived as sector-specific duties on the horizon
Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Pharmaceutical companies breathed ...

Europe’s pharma industry braces for tariffs as carve-out hopes fade
SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT JFK AIRPORT’S INTERNATIONAL MAIL FACILITY. CNBC COPENHAGEN, Denmark — Europe’s pharmaceutical ...

Novo Nordisk’s diabetes pill Rybelsus slashes cardiovascular risk
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for ...

Obesity drug CagriSema will be important product
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, ...

Drug compounders hit Wegovy sales, may take legal action
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy ...

23andMe users urged to delete their data. Here’s how
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...

Novo Nordisk’s next-gen obesity drug CagriSema trial results disappoint investors
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto ...